These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis. Ribecco-Lutkiewicz M; Sodja C; Haukenfrers J; Haqqani AS; Ly D; Zachar P; Baumann E; Ball M; Huang J; Rukhlova M; Martina M; Liu Q; Stanimirovic D; Jezierski A; Bani-Yaghoub M Sci Rep; 2018 Jan; 8(1):1873. PubMed ID: 29382846 [TBL] [Abstract][Full Text] [Related]
3. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies. Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826 [TBL] [Abstract][Full Text] [Related]
4. Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line. Ozgür B; Puris E; Brachner A; Appelt-Menzel A; Oerter S; Balzer V; Holst MR; Christiansen RF; Hyldig K; Buckley ST; Kristensen M; Auriola S; Jensen A; Fricker G; Nielsen MS; Neuhaus W; Brodin B Fluids Barriers CNS; 2023 Dec; 20(1):96. PubMed ID: 38115090 [TBL] [Abstract][Full Text] [Related]
5. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS. Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493 [TBL] [Abstract][Full Text] [Related]
6. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs. Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318 [TBL] [Abstract][Full Text] [Related]
7. The maturation of iPS cell-derived brain microvascular endothelial cells by inducible-SOX18 expression. Zhang H; Yamaguchi T; Kawabata K Fluids Barriers CNS; 2023 Feb; 20(1):10. PubMed ID: 36732767 [TBL] [Abstract][Full Text] [Related]
9. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. Clark PA; Al-Ahmad AJ; Qian T; Zhang RR; Wilson HK; Weichert JP; Palecek SP; Kuo JS; Shusta EV Mol Pharm; 2016 Sep; 13(9):3341-9. PubMed ID: 27421304 [TBL] [Abstract][Full Text] [Related]
10. Development of a Blood-Brain Barrier Permeability Assay Using Human Induced Pluripotent Stem Cell Derived Brain Endothelial Cells. Charlebois C; Huang J; Sodja C; Ribecco-Lutkiewicz M; Baumann E; Stanimirovic DB; Jezierski A Methods Mol Biol; 2022; 2454():397-410. PubMed ID: 33881753 [TBL] [Abstract][Full Text] [Related]
11. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy. De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824 [TBL] [Abstract][Full Text] [Related]
12. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells. Hollmann EK; Bailey AK; Potharazu AV; Neely MD; Bowman AB; Lippmann ES Fluids Barriers CNS; 2017 Apr; 14(1):9. PubMed ID: 28407791 [TBL] [Abstract][Full Text] [Related]
13. Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport. Molino Y; Jabès F; Lacassagne E; Gaudin N; Khrestchatisky M J Vis Exp; 2014 Jun; (88):e51278. PubMed ID: 24998179 [TBL] [Abstract][Full Text] [Related]